Click here to get full coverage on Norges Bank Invests $29.58 Million in Summit Therapeutics PLC $SMMT - MarketBeat

Norges Bank Invests $29.58 Million in Summit Therapeutics PLC $SMMT  MarketBeat

Norges Bank Invests $29.58 Million in Summit Therapeutics PLC $SMMT - MarketBeat

Click here to get full coverage on UK LCV registrations decline in November 2025: SMMT - Yahoo Finance

UK LCV registrations decline in November 2025: SMMT  Yahoo Finance

UK LCV registrations decline in November 2025: SMMT - Yahoo Finance

Click here to get full coverage on UK new car market expected to fall slightly in November, SMMT data shows - Reuters

UK new car market expected to fall slightly in November, SMMT data shows  Reuters

UK new car market expected to fall slightly in November, SMMT data shows - Reuters

Click here to get full coverage on New Members – November - SMMT

New Members – November - SMMT

Click here to get full coverage on SMMT announces new President - Just Auto

SMMT announces new President  Just Auto

SMMT announces new President - Just Auto

Click here to get full coverage on EV growth lowest in two years says SMMT - Electrifying.com

EV growth lowest in two years says SMMT  Electrifying.com

EV growth lowest in two years says SMMT - Electrifying.com

Click here to get full coverage on Summit Therapeutics (NASDAQ: SMMT) issues 67,483 inducement stock options to new hires - Stock Titan

Summit Therapeutics (NASDAQ: SMMT) issues 67,483 inducement stock options to new hires  Stock Titan

Summit Therapeutics (NASDAQ: SMMT) issues 67,483 inducement stock options to new hires - Stock Titan

Click here to get full coverage on Summit Therapeutics (SMMT): Rethinking Valuation After Weak Earnings and Notable Insider Buying - simplywall.st

Summit Therapeutics (SMMT): Rethinking Valuation After Weak Earnings and Notable Insider Buying  simplywall.st

Summit Therapeutics (SMMT): Rethinking Valuation After Weak Earnings and Notable Insider Buying - simplywall.st

Click here to get full coverage on Deloitte comments on SMMT car reg figures for November 2025 - Deloitte

Deloitte comments on SMMT car reg figures for November 2025  Deloitte

Deloitte comments on SMMT car reg figures for November 2025 - Deloitte

Click here to get full coverage on Wolfe Research Initiates Coverage of Summit Therapeutics (SMMT) with Peer Perform Recommendation - Nasdaq

Wolfe Research Initiates Coverage of Summit Therapeutics (SMMT) with Peer Perform Recommendation  Nasdaq

Wolfe Research Initiates Coverage of Summit Therapeutics (SMMT) with Peer Perform Recommendation - Nasdaq

Click here to get full coverage on Summit Therapeutics (SMMT) Reports Positive Results from the Phase III HARMONi Trial - Yahoo Finance

Summit Therapeutics (SMMT) Reports Positive Results from the Phase III HARMONi Trial  Yahoo Finance

Summit Therapeutics (SMMT) Reports Positive Results from the Phase III HARMONi Trial - Yahoo Finance

Click here to get full coverage on November new car market struggles ahead of Budget drag on demand - SMMT

November new car market struggles ahead of Budget drag on demand  SMMT

November new car market struggles ahead of Budget drag on demand - SMMT

Click here to get full coverage on UK new car market sees slight rise in October, SMMT data shows - Reuters

UK new car market sees slight rise in October, SMMT data shows  Reuters

UK new car market sees slight rise in October, SMMT data shows - Reuters

Click here to get full coverage on Summit Therapeutics (SMMT): Valuation Check After Weak Q3 2025 Results and Insider Share Purchases - Yahoo Finance

Summit Therapeutics (SMMT): Valuation Check After Weak Q3 2025 Results and Insider Share Purchases  Yahoo Finance

Summit Therapeutics (SMMT): Valuation Check After Weak Q3 2025 Results and Insider Share Purchases - Yahoo Finance

Click here to get full coverage on SMMT statement on Automated Vehicles consultation - SMMT

SMMT statement on Automated Vehicles consultation  SMMT

SMMT statement on Automated Vehicles consultation - SMMT

Click here to get full coverage on A Look at Summit Therapeutics (SMMT) Valuation Following Positive HARMONi Trial Results and Regulatory Progress - Yahoo Finance

A Look at Summit Therapeutics (SMMT) Valuation Following Positive HARMONi Trial Results and Regulatory Progress  Yahoo Finance

A Look at Summit Therapeutics (SMMT) Valuation Following Positive HARMONi Trial Results and Regulatory Progress - Yahoo Finance

Click here to get full coverage on Summit Therapeutics (SMMT): A Valuation Perspective After Recent 16% Share Price Climb - Yahoo Finance

Summit Therapeutics (SMMT): A Valuation Perspective After Recent 16% Share Price Climb  Yahoo Finance

Summit Therapeutics (SMMT): A Valuation Perspective After Recent 16% Share Price Climb - Yahoo Finance

Click here to get full coverage on Summit Therapeutics (SMMT) Expands its Phase 3 Trials for Ivonescimab - Yahoo Finance

Summit Therapeutics (SMMT) Expands its Phase 3 Trials for Ivonescimab  Yahoo Finance

Summit Therapeutics (SMMT) Expands its Phase 3 Trials for Ivonescimab - Yahoo Finance

Click here to get full coverage on Summit Therapeutics (SMMT) Is Down 6.4% After $513M Shelf Filing and Ivonescimab Clinical Updates—Has The Bull Case Changed? - Yahoo Finance

Summit Therapeutics (SMMT) Is Down 6.4% After $513M Shelf Filing and Ivonescimab Clinical Updates—Has The Bull Case Changed?  Yahoo Finance

Summit Therapeutics (SMMT) Is Down 6.4% After $513M Shelf Filing and Ivonescimab Clinical Updates—Has The Bull Case Changed? - Yahoo Finance

Click here to get full coverage on Summit Therapeutics Inc (SMMT) Q3 2025 Earnings Call Highlights: Promising Clinical ... - Yahoo Finance

Summit Therapeutics Inc (SMMT) Q3 2025 Earnings Call Highlights: Promising Clinical ...  Yahoo Finance

Summit Therapeutics Inc (SMMT) Q3 2025 Earnings Call Highlights: Promising Clinical ... - Yahoo Finance

Click here to get full coverage on November new car market dips as SMMT warns EV tax plan risks demand - AM-online

November new car market dips as SMMT warns EV tax plan risks demand  AM-online

November new car market dips as SMMT warns EV tax plan risks demand - AM-online

Click here to get full coverage on Guggenheim Initiates Summit Therapeutics (SMMT) With a Buy Rating - Yahoo Finance

Guggenheim Initiates Summit Therapeutics (SMMT) With a Buy Rating  Yahoo Finance

Guggenheim Initiates Summit Therapeutics (SMMT) With a Buy Rating - Yahoo Finance

Click here to get full coverage on $SMMT stock is down 4% today. Here's what we see in our data. - Quiver Quantitative

$SMMT stock is down 4% today. Here's what we see in our data.  Quiver Quantitative

$SMMT stock is down 4% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Insider Buying After Losses Could Be a Game Changer for Summit Therapeutics (SMMT) - simplywall.st

Insider Buying After Losses Could Be a Game Changer for Summit Therapeutics (SMMT)  simplywall.st

Insider Buying After Losses Could Be a Game Changer for Summit Therapeutics (SMMT) - simplywall.st

Click here to get full coverage on SMMT's Q3 Loss Wider Than Expected, Stock Down on Study Amendments - Yahoo Finance

SMMT's Q3 Loss Wider Than Expected, Stock Down on Study Amendments  Yahoo Finance

SMMT's Q3 Loss Wider Than Expected, Stock Down on Study Amendments - Yahoo Finance

Click here to get full coverage on A Look at Summit Therapeutics (SMMT) Valuation Following Phase III Trial Setback and Legal Investigation - Yahoo Finance

A Look at Summit Therapeutics (SMMT) Valuation Following Phase III Trial Setback and Legal Investigation  Yahoo Finance

A Look at Summit Therapeutics (SMMT) Valuation Following Phase III Trial Setback and Legal Investigation - Yahoo Finance

Click here to get full coverage on XTX Topco Ltd Makes New $925,000 Investment in Summit Therapeutics PLC $SMMT - MarketBeat

XTX Topco Ltd Makes New $925,000 Investment in Summit Therapeutics PLC $SMMT  MarketBeat

XTX Topco Ltd Makes New $925,000 Investment in Summit Therapeutics PLC $SMMT - MarketBeat

Click here to get full coverage on Summit Therapeutics (SMMT) Releases Financial Results and Updates on Operational Progress for Q3 2025 - Yahoo Finance

Summit Therapeutics (SMMT) Releases Financial Results and Updates on Operational Progress for Q3 2025  Yahoo Finance

Summit Therapeutics (SMMT) Releases Financial Results and Updates on Operational Progress for Q3 2025 - Yahoo Finance

Click here to get full coverage on Wolfe Research Initiates Coverage on SMMT with 'Peer Perform' Ra - GuruFocus

Wolfe Research Initiates Coverage on SMMT with 'Peer Perform' Ra  GuruFocus

Wolfe Research Initiates Coverage on SMMT with 'Peer Perform' Ra - GuruFocus

Click here to get full coverage on H.C. Wainwright Lifts PT on Summit Therapeutics (SMMT) to $50 From $44 - Yahoo Finance

H.C. Wainwright Lifts PT on Summit Therapeutics (SMMT) to $50 From $44  Yahoo Finance

H.C. Wainwright Lifts PT on Summit Therapeutics (SMMT) to $50 From $44 - Yahoo Finance

Click here to get full coverage on Summit Therapeutics (SMMT) Nosedives 9% on Dismal Earnings, Absence of Investor Call - Yahoo Finance

Summit Therapeutics (SMMT) Nosedives 9% on Dismal Earnings, Absence of Investor Call  Yahoo Finance

Summit Therapeutics (SMMT) Nosedives 9% on Dismal Earnings, Absence of Investor Call - Yahoo Finance

Click here to get full coverage on SMMT Stock Plummets 25% on Regional Data Differences in NSCLC Study - September 9, 2025 - Zacks Investment Research

SMMT Stock Plummets 25% on Regional Data Differences in NSCLC Study - September 9, 2025  Zacks Investment Research

SMMT Stock Plummets 25% on Regional Data Differences in NSCLC Study - September 9, 2025 - Zacks Investment Research

Click here to get full coverage on New car sales dip despite EV growth – SMMT - Bodyshop Magazine

New car sales dip despite EV growth – SMMT  Bodyshop Magazine

New car sales dip despite EV growth – SMMT - Bodyshop Magazine

Click here to get full coverage on SMMT January 2026 Options Begin Trading - Nasdaq

SMMT January 2026 Options Begin Trading  Nasdaq

SMMT January 2026 Options Begin Trading - Nasdaq

Click here to get full coverage on Summit Therapeutics Inc. (SMMT) Faces Volatile 2025 as Ivonescimab Gains Approval in China - Yahoo Finance

Summit Therapeutics Inc. (SMMT) Faces Volatile 2025 as Ivonescimab Gains Approval in China  Yahoo Finance

Summit Therapeutics Inc. (SMMT) Faces Volatile 2025 as Ivonescimab Gains Approval in China - Yahoo Finance

Click here to get full coverage on SMMT Stock Gains on Rumored Licensing Talks With AstraZeneca - Yahoo Finance

SMMT Stock Gains on Rumored Licensing Talks With AstraZeneca  Yahoo Finance

SMMT Stock Gains on Rumored Licensing Talks With AstraZeneca - Yahoo Finance

Click here to get full coverage on Van market declines in November but EV demand grows - SMMT

Van market declines in November but EV demand grows  SMMT

Van market declines in November but EV demand grows - SMMT

Click here to get full coverage on Summit Therapeutics Stock (SMMT) Opinions on Insider Buying and Q3 Results | SMMT Stock News - Quiver Quantitative

Summit Therapeutics Stock (SMMT) Opinions on Insider Buying and Q3 Results | SMMT Stock News  Quiver Quantitative

Summit Therapeutics Stock (SMMT) Opinions on Insider Buying and Q3 Results | SMMT Stock News - Quiver Quantitative

Click here to get full coverage on UK van buyers vanish: registrations plunge to crisis levels - Trans.INFO

UK van buyers vanish: registrations plunge to crisis levels  Trans.INFO

UK van buyers vanish: registrations plunge to crisis levels - Trans.INFO

Click here to get full coverage on Paul Philpott appointed new SMMT President - SMMT

Paul Philpott appointed new SMMT President  SMMT

Paul Philpott appointed new SMMT President - SMMT

Click here to get full coverage on Peter Kyle addresses guests at the SMMT Annual Dinner - GOV.UK

Peter Kyle addresses guests at the SMMT Annual Dinner  GOV.UK

Peter Kyle addresses guests at the SMMT Annual Dinner - GOV.UK

Click here to get full coverage on Summit Therapeutics (SMMT) Jumps 7.6% on Reports of $15-Billion AstraZeneca Deal - Yahoo Finance

Summit Therapeutics (SMMT) Jumps 7.6% on Reports of $15-Billion AstraZeneca Deal  Yahoo Finance

Summit Therapeutics (SMMT) Jumps 7.6% on Reports of $15-Billion AstraZeneca Deal - Yahoo Finance

Click here to get full coverage on Summit Therapeutics (SMMT) Climbs 16% Ahead of Q2 Earnings - Yahoo Finance

Summit Therapeutics (SMMT) Climbs 16% Ahead of Q2 Earnings  Yahoo Finance

Summit Therapeutics (SMMT) Climbs 16% Ahead of Q2 Earnings - Yahoo Finance

Click here to get full coverage on $SMMT stock is down 3% today. Here's what we see in our data. - Quiver Quantitative

$SMMT stock is down 3% today. Here's what we see in our data.  Quiver Quantitative

$SMMT stock is down 3% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on SMMT Q2 Loss Wider Than Expected, Ivonescimab Studies in Focus - Zacks Investment Research

SMMT Q2 Loss Wider Than Expected, Ivonescimab Studies in Focus  Zacks Investment Research

SMMT Q2 Loss Wider Than Expected, Ivonescimab Studies in Focus - Zacks Investment Research

Click here to get full coverage on Used EV sales surge 44% as motor finance sector reacts to SMMT Q3 data - Yahoo Finance

Used EV sales surge 44% as motor finance sector reacts to SMMT Q3 data  Yahoo Finance

Used EV sales surge 44% as motor finance sector reacts to SMMT Q3 data - Yahoo Finance

Click here to get full coverage on Summit Therapeutics (SMMT) Is Down 21.0% After Mixed HARMONi Trial Data Raises Global Approval Questions - Yahoo Finance

Summit Therapeutics (SMMT) Is Down 21.0% After Mixed HARMONi Trial Data Raises Global Approval Questions  Yahoo Finance

Summit Therapeutics (SMMT) Is Down 21.0% After Mixed HARMONi Trial Data Raises Global Approval Questions - Yahoo Finance

Click here to get full coverage on January 2026 Options Now Available For Summit Therapeutics (SMMT) - Nasdaq

January 2026 Options Now Available For Summit Therapeutics (SMMT)  Nasdaq

January 2026 Options Now Available For Summit Therapeutics (SMMT) - Nasdaq

Click here to get full coverage on New van registrations decline in November - SMMT

New van registrations decline in November  SMMT

New van registrations decline in November - SMMT

Click here to get full coverage on New car market shrinks in August but EVs reach record share for the year - SMMT

New car market shrinks in August but EVs reach record share for the year  SMMT

New car market shrinks in August but EVs reach record share for the year - SMMT

Click here to get full coverage on UK’s automotive remanufacturing industry could drive economy: SMMT - Yahoo Finance

UK’s automotive remanufacturing industry could drive economy: SMMT  Yahoo Finance

UK’s automotive remanufacturing industry could drive economy: SMMT - Yahoo Finance

Click here to get full coverage on New car market holds steady in October but new tax policy threatens market decline - SMMT

New car market holds steady in October but new tax policy threatens market decline  SMMT

New car market holds steady in October but new tax policy threatens market decline - SMMT

Click here to get full coverage on Duggan buys Summit Therapeutics (SMMT) shares worth $5.9m - Investing.com

Duggan buys Summit Therapeutics (SMMT) shares worth $5.9m  Investing.com

Duggan buys Summit Therapeutics (SMMT) shares worth $5.9m - Investing.com

Click here to get full coverage on A disquieting month for the UK’s new car market - SMMT

A disquieting month for the UK’s new car market  SMMT

A disquieting month for the UK’s new car market - SMMT

Click here to get full coverage on SMMT: New car market shrinks in August but EVs reach record share for the year - Automotive World

SMMT: New car market shrinks in August but EVs reach record share for the year  Automotive World

SMMT: New car market shrinks in August but EVs reach record share for the year - Automotive World

Click here to get full coverage on Summit Therapeutics (NASDAQ: SMMT) raises $500M; insiders invest $282M in private placement - Stock Titan

Summit Therapeutics (NASDAQ: SMMT) raises $500M; insiders invest $282M in private placement  Stock Titan

Summit Therapeutics (NASDAQ: SMMT) raises $500M; insiders invest $282M in private placement - Stock Titan

Click here to get full coverage on Barclays Maintains Summit Therapeutics (SMMT) Underweight Recommendation - Nasdaq

Barclays Maintains Summit Therapeutics (SMMT) Underweight Recommendation  Nasdaq

Barclays Maintains Summit Therapeutics (SMMT) Underweight Recommendation - Nasdaq

Click here to get full coverage on UK car production drops 23.8% in October 2025: SMMT - Motor Finance Online

UK car production drops 23.8% in October 2025: SMMT  Motor Finance Online

UK car production drops 23.8% in October 2025: SMMT - Motor Finance Online

Click here to get full coverage on Cyber attack hits vehicle output with new risk arising from tax charge on auto workers - SMMT

Cyber attack hits vehicle output with new risk arising from tax charge on auto workers  SMMT

Cyber attack hits vehicle output with new risk arising from tax charge on auto workers - SMMT

Click here to get full coverage on Vehicle production down in October but growth on the horizon - SMMT

Vehicle production down in October but growth on the horizon  SMMT

Vehicle production down in October but growth on the horizon - SMMT

Click here to get full coverage on Summit Therapeutics stock gains on insider buys (SMMT:NASDAQ) - Seeking Alpha

Summit Therapeutics stock gains on insider buys (SMMT:NASDAQ)  Seeking Alpha

Summit Therapeutics stock gains on insider buys (SMMT:NASDAQ) - Seeking Alpha

Click here to get full coverage on New car registrations stall in July but recovery expected - SMMT

New car registrations stall in July but recovery expected  SMMT

New car registrations stall in July but recovery expected - SMMT

Click here to get full coverage on UK: Electrified Autos Over 50% Again as EV Sales Hit 26% - Electric Cars Report

UK: Electrified Autos Over 50% Again as EV Sales Hit 26%  Electric Cars Report

UK: Electrified Autos Over 50% Again as EV Sales Hit 26% - Electric Cars Report

Click here to get full coverage on Summit Therapeutics Inc. (SMMT): Among the Best Cancer Stocks to Invest in for Long-Term Gain - Yahoo Finance

Summit Therapeutics Inc. (SMMT): Among the Best Cancer Stocks to Invest in for Long-Term Gain  Yahoo Finance

Summit Therapeutics Inc. (SMMT): Among the Best Cancer Stocks to Invest in for Long-Term Gain - Yahoo Finance

Click here to get full coverage on Final Trade: NVS, XLU and SMMT - CNBC

Final Trade: NVS, XLU and SMMT - CNBC

Click here to get full coverage on Wall Street Analysts Believe Summit Therapeutics (SMMT) Could Rally 63.02%: Here's is How to Trade - Nasdaq

Wall Street Analysts Believe Summit Therapeutics (SMMT) Could Rally 63.02%: Here's is How to Trade  Nasdaq

Wall Street Analysts Believe Summit Therapeutics (SMMT) Could Rally 63.02%: Here's is How to Trade - Nasdaq

Click here to get full coverage on Summit Therapeutics (NasdaqGM:SMMT) Reports US$63M Net Loss For Q1 2025 - Yahoo Finance

Summit Therapeutics (NasdaqGM:SMMT) Reports US$63M Net Loss For Q1 2025  Yahoo Finance

Summit Therapeutics (NasdaqGM:SMMT) Reports US$63M Net Loss For Q1 2025 - Yahoo Finance

Click here to get full coverage on Does Summit Therapeutics (SMMT) Have the Potential to Rally 44.6% as Wall Street Analysts Expect? - Yahoo Finance

Does Summit Therapeutics (SMMT) Have the Potential to Rally 44.6% as Wall Street Analysts Expect?  Yahoo Finance

SMMT

Price Chart

Key Statistics

Technicals

About SMMT

Latest News

Norges Bank Invests $29.58 Million in Summit Therapeutics PLC $SMMT - MarketBeat

UK LCV registrations decline in November 2025: SMMT - Yahoo Finance

UK new car market expected to fall slightly in November, SMMT data shows - Reuters

Advanced Charts

Top Gainers

Top Losers